Melbourne, Australia; 8 April 2024: Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce that it will host an investor webinar on Tuesday, 9 April 2024.

The session will cover the ASX Announcement lodged today about the strategic partnership with Medicxi and the formation of a new company called Petalion Therapeutics Limited (“Petalion”).

The webinar will be hosted by Starpharma’s CEO, Cheryl Maley. Dr Mehdi Shahidi, CEO of Petalion and Venture Partner at Medicxi, and Shyam Masrani, Principal at Medicxi and Board representative of Petalion, will also join the call.

Investors can submit questions during the webinar, but in the best interest of time, shareholders are encouraged to send any questions to investor.relations@starpharma.com before the webinar.

Webinar details

Date: Tuesday, 9 April 2024

Time: 11:00 AM AEST (Melbourne/Sydney) / 09:00 AM AWST (Perth)

Link to register: https://us02web.zoom.us/webinar/register/WN_V69z91NqTbGy3OV9MuDMYg

Starpharma will host a separate investor webinar in early May, which will provide an update on Starpharma’s business. Shareholders will be provided information on how to attend via the ASX markets announcements platform.

About Medicxi

Medicxi is a healthcare-focused investment firm with the mission to create and invest in companies across the full drug development continuum. Leveraging deep expertise in drug development and company creation spanning over two decades, Medicxi invests in early and late-stage therapeutics with a product vision that can fulfil a clear unmet medical need.

For more information, please visit www.medicxi.com.

View/download the ASX Announcement: Investor Webinar Notification – Starpharma x Medicxi Partnership.